- $74.06m
- $33.70m
- 15
- 36
- 56
- 28
Annual balance sheet for Medicinova, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 60 | 71.4 | 58.5 | 51 | 40.4 |
| Prepaid Expenses | |||||
| Total Current Assets | 60.7 | 72 | 59 | 51.2 | 41.1 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.056 | 0.882 | 0.675 | 0.621 | 0.382 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Other Long Term Assets | |||||
| Total Assets | 75.4 | 87.4 | 74.2 | 66.3 | 55.9 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Current Liabilities | 2.19 | 2.83 | 3.19 | 3.28 | 2.96 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 4.09 | 3.73 | 3.91 | 3.89 | 3.37 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 71.3 | 83.7 | 70.2 | 62.4 | 52.5 |
| Total Liabilities & Shareholders' Equity | 75.4 | 87.4 | 74.2 | 66.3 | 55.9 |
| Total Common Shares Outstanding |